Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy
Cellular Oncology · 2025-04 · 48 (2) · 295-312
DOI: 10.1007/s13402-024-00992-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Oncology, online erschienen am 26.09.2024. Verfasst von Monika Ryba-Stanisławowska. Beteiligte Einrichtung: Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1, Gdańsk, 80-211, Poland. monika.ryba-stanislawowska@gu…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, T-Lymphocytes, Helper-Inducer, T-Lymphocyte Subsets. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
T helper (Th) cell subsets play pivotal roles in regulating immune responses within the tumor microenvironment, influencing both tumor progression and anti-tumor immunity. Among these subsets, Th1 cells promote cytotoxic responses through the production of IFN-γ, while Th2 cells and regulatory T cells (Tregs) exert immunosuppressive effects that support tumor growth. Th9 and Th17 cells have context-dependent roles, contributing to both pro-inflammatory and regulatory processes in tumor immunity. Tumor antigen-specific T cells within the tumor microenvironment often exhibit a dysfunctional phenotype due to increased expression of inhibitory receptors such as CTLA-4 and PD-1, leading to reduced antitumor activity. Monoclonal antibodies that block these inhibitory signals—collectively known as immune checkpoint inhibitors (ICIs)—can reactivate these T cells, enhancing their ability to target and destroy cancer cells. Recent advancements have highlighted the critical role of T helper subsets in modulating responses to ICIs, with their interactions remaining a focus of ongoing research. Both positive and negative effects of ICIs have been reported in relation to Th cell subsets, with some effects depending on the type of tumor microenvironment. This review summarizes the crucial roles of different T helper cell subsets in tumor immunity and their complex relationship with immune checkpoint inhibitor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1, Gdańsk, 80-211, Poland. monika.ryba-stanislawowska@gumed.edu.pl.
ORCID-Profile: Monika Ryba-Stanisławowska
Zitieren
APA
Ryba-Stanisławowska, M. (2025). Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy. Cellular Oncology, 48(2), 295-312. https://doi.org/10.1007/s13402-024-00992-0
Vancouver
Ryba-Stanisławowska M. Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy. Cellular Oncology. 2025;48(2):295-312. doi:10.1007/s13402-024-00992-0
BibTeX
@article{RybaStanisawowska2025,
author = {Ryba-Stanisławowska, Monika},
title = {Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy},
journal = {Cellular Oncology},
year = {2025},
volume = {48},
number = {2},
pages = {295--312},
doi = {10.1007/s13402-024-00992-0}
}
EUVIMED